Clinical Study

The Preoperative Maximum Standardized Uptake Value Measured by 18F-FDG PET/CT as an Independent Prognostic Factor of Overall Survival in Endometrial Cancer Patients

Table 2

The mean SUVmax in relation to pathological parameters.

MeanStandard deviation (SD)Lower quartile (Q1)Median (Me)Upper quartile (Q3)

FIGO stage
 IA11.456.147.609.7013.60a0.0012
 IB14.614.3711.1015.2017.35b
 II17.095.7516.4019.5020.40b
 III + IV17.557.9014.0018.1019.20b
Lymph nodes metastasis
 Positive17.1512.129.4015.0024.900.8191
 Negative14.205.579.3014.1518.15
Depth of myometrial invasion
 ≥50%15.595.0212.2015.6019.000.0016
 <50%12.166.657.4010.1016.10
Grading
 111.254.709.109.2015.20a0.0180
 214.455.949.4014.4018.20ab
 316.665.4612.1016.2020.20b
Histopathological subtype (Bokham type)
 114.125.829.2014.3018.100.3813
 216.316.1212.2014.2020.20
Death (before 60 months)
 Yes17.145.0914.2017.1019.350.0055
 No13.475.839.1012.8017.40
Risk groups
 Low11,456,147,609,7013,600,0004
 Intermediate14,244,2010,4015,2017,10
 High16,926,2812,9017,8020,25